Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.

نویسندگان

  • R Shapiro
  • M L Jordan
  • V P Scantlebury
  • C Vivas
  • H A Gritsch
  • J McCauley
  • D McQuitty
  • P Randhawa
  • W Irish
  • J McMichael
  • T R Hakala
  • R L Simmons
  • J J Fung
  • T E Starzl
چکیده

N 289 (76%) 90 (24%) Median time to withdrawal (months) 10 Uving donor 92% 8% Cadaveric donor' 75% 25% Donor age (y)' 32.9:!: 19.8 38.8: 21.4 Donors <60 y 79% 21% Donors >60 y" 53% 47% Tacrolimuslprednisone 77% 22% Tacrolimuslprednisonelazathioprine 76% 23% Delayed graft function ... no 81% 19% yes 67% 33% Acute rejection .. no 87% 13% 65% 35% Patient survivalt 1 y (actual) 99% 91% 3 Y (actuarial) 98% 80% Graft survivalt 1 y (actual) 98% 77% 3 Y (actuarial) 94% 50% Rejectiont 43% 73% Serum creatinine (mgldL) 1 y" 1.6 :t 0.6 2.3: 1.5 2 ytt 1.7:0.7 2.3: 1.3 Cytomegalovirus 15% 23% Tacrolimus dose (mglkg per d) 1 yttt 0.15: 0.11 0.19:!: 0.15 2 ytttt 0.13 :t 0.08 0.18:!: 0.09

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.

CORTICOSTEROIDS, in spite of their well-known side effects, have essentially always been an integral part of immunosuppressive regimens in renal transplantation. With the introduction of tacrolimus, however, steroid withdrawal has been possible in some 70% of successfully transplanted adults and children. 1-8 An important question, however, concerns the outcome after steroid withdrawal in adult...

متن کامل

Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.

BACKGROUND Corticosteroids have always been an integral part of immunosuppressive regimens in renal transplantation. The primary goal of this analysis was to assess the safety of steroid withdrawal in our pediatric renal transplant recipients receiving tacrolimus-based immunosuppression. METHODS Between December 1989 and December 1996, 82 renal transplantations were performed in pediatric pat...

متن کامل

Role of Immunosuppression Minimization Protocols in Renal Transplantation

The subject of transplant immunosuppression has generated significant interest in recent years. Excellent immunosuppression, advances in surgical technique, post-transplantation care, and infection control have resulted in excellent outcomes. There is widespread support for the notion that the fundamental objective in transplant immunology should be the achievement of specific graft toleran...

متن کامل

Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis.

Data from seven randomized, prospective trials were pooled to determine the effect of steroid-free immunosuppression on allograft survival, patient survival, and the incidence of acute allograft rejection in renal transplant recipients receiving cyclosporine-based maintenance immunosuppression. Six of the seven trials incorporated into this analysis examined the effects of either complete avoid...

متن کامل

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients

During the past few years, new immunosuppressants, such as tacrolimus, mycophenolate mofetil (MMF) and basiliximab, have been shown to successfully decrease the incidence of acute rejection, possibly acting as potent substrates for safe steroid withdrawal. Therefore, clinical outcome of 3 months steroid withdrawal, while using the above immunosuppressants, was analyzed. Clinical trial registry ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Transplantation proceedings

دوره 30 4  شماره 

صفحات  -

تاریخ انتشار 1998